Marinomed Biotechnologie GmbH presents its first product - Carragelose(R) in the nasal spray COLDAMARIS prophylactic
>> A new innovative treatment against common cold out of the sea
(Vienna, 27. 2. 2008) After less than two years the biotech company Marinomed Biotechnologie GmbH presents its first product: Carragelose® in the nasal spray COLDAMARIS prophylactic is the new effective and novel treatment against common cold.
Marinomed developed the innovative nasal spray in cooperation with Sigmapharm Arzneimittel GmbH & Co KG, an Austrian company with long tradition in common cold products. The nasal spray COLDAMARIS prophylactic protects the nasal mucosa with a layer from outside impacts due to dryness and irritation. It is suitable for every age class starting from the age of infants. Because of its new composition the exposure time of the protective layer on the mucosa increases and dripping out of the solution is prevented. The spray does not contain preservatives and therefore the function of the ciliated epithelium remains intact.
The nasal spray COLDAMARIS prophylactic, which is marketed exclusively by pharmacies, is especially effective as early treatment but may also be used during an ongoing respiratory infection. It supports the natural defence of the body against viruses and germs.
The nasal spray COLDAMARIS prophylactic expands the existing product line “COLDAMARIS” of the traditional Austrian company Sigmapharm with a promising new product. Marinomed Biotechnologie GmbH was founded in 2006 and develops therapies based on marine natural products against infectious diseases and immunological based disorders.
Marinomed Biotechnologie GmbH is a spin-off company of the Veterinary University Vienna. The company with its specialists in the fields of infectious diseases, immunology and marine biotechnology is focussed on the development of therapies based on marine natural products. Last year Marinomed won the first prize at the “Wiener Zukunftspreis 07” (Vienna Innovation Prize 07).
Contact for further information:
Marinomed Biotechnologie GmbH
Veterinärplatz 1 1210 Vienna Austria Tel: +43-1-25077-4460 Fax: +43-1-25077-4493 E-Mail: Johanna.uhlmann(at)marinomed.com
Sigmapharm Arzneimittel GmbH & Co KG
Leystraße 129 1200 Vienna Austria Tel: +43-(0)1-330 06 71-0 Fax: +43-(0)1-330 06 71-38 E-Mail: mail(at)sigmapharm.at